| | |
Time
|
ANOVA (p)
|
|---|
|
Parameters
| |
Baseline
|
6 months
|
Group effect
|
Time effect
|
Group x Time interaction
|
|---|
|
Total Weight (Kg)
|
CG (n = 26)
|
76.94 ± 11.07
|
77.62 ± 12.14
|
0.001
|
0.2
|
0.11
|
|
AG (n = 24)
|
65.55 ± 7.55
|
64.73 ± 7.83
|
|
∑6 Skinfold (mm)
|
CG (n = 26)
|
62.76 ± 12.23
|
63.02 ± 13.05
|
0.001
|
0.08
|
0.13
|
|
AG (n = 24)
|
48.74 ± 11.17
|
46.59 ± 8.89
|
|
Rest HR (b/min)
|
CG (n = 26)
|
65.12 ± 12.42
|
67.34 ± 11.71
|
0.001
|
0.13
|
0.21
|
|
AG (n = 24)
|
52.12 ± 12.42
|
49.87 ± 9.27
|
|
HR max (b/min)
|
CG (n = 26)
|
196.33 ± 7.55
|
197.41 ± 8.01
|
0.42
|
0.51
|
0.72
|
|
AG (n = 24)
|
193.69 ± 7.85
|
194.30 ± 7.50
|
|
VO2 max (ml/kg/min)
|
CG (n = 26)
|
45.72 ± 7.51
|
46.32 ± 8.16
|
0.001
|
0.2
|
0.31
|
|
AG (n = 24)
|
66.46 ± 10.12
|
67.94 ± 8.10
|
|
VE max (L/min)
|
CG (n = 26)
|
98.66 ± 11.47
|
99.26 ± 16.63
|
0.001
|
0.42
|
0.25
|
|
AG (n = 24)
|
137.95 ± 55.34
|
129.00 ± 26.92
|
- CG Control group, AG Athletes’ group, HR Heart rate. VO2 Oxygen uptake, VE Pulmonary ventilation
- Values are presented as mean ± standard deviation